Literature DB >> 9989780

Regulation of the high-affinity H+/peptide cotransporter in renal LLC-PK1 cells.

U Wenzel1, D Diehl, M Herget, S Kuntz, H Daniel.   

Abstract

Di- and tripeptides and peptide mimetics such as beta-lactam antibiotics are efficiently reabsorbed from the tubular lumen by a high-affinity peptide transporter. We have recently identified and characterized this H+-coupled high-affinity peptide transport system in the porcine proximal tubular cell line LLC-PK1. Here we describe for the first time the regulation of the renal high-affinity peptide cotransporter at the cellular level. Uptake of 5 microM 3H-D-Phe-L-Ala into LLC-PK1 cells was significantly increased by lowering [Ca2+]in and decreased by increasing [Ca2+] in. Moreover, it was shown that the [Ca2+]in effects on peptide transport activity were dependent on Ca2+ entry from the extracellular site (e.g., via a store-regulated capacitative Ca2+ influx). Protein kinase C (PKC) was found to transmit the effects of [Ca2+]in on peptide transport. Although we demonstrate by pHin measurements that the PKC inhibitor staurosporine did decrease the transmembrane H+ gradient and consequently should have reduced the driving force for peptide uptake, the only effect on transport kinetics of 3H-D-Phe-L-Ala observed was a significant decrease in Km from 22.7+/-2.5 microM to 10.2+/-1.9 microM with no change in maximal velocity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9989780     DOI: 10.1002/(SICI)1097-4652(199903)178:3<341::AID-JCP8>3.0.CO;2-H

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

1.  Distribution and function of the peptide transporter PEPT2 in normal and cystic fibrosis human lung.

Authors:  D A Groneberg; P R Eynott; F Döring; Q Thai Dinh; T Oates; P J Barnes; K F Chung; H Daniel; A Fischer
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

2.  Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake.

Authors:  D A Groneberg; M Nickolaus; J Springer; F Döring; H Daniel; A Fischer
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

3.  PEPT1-mediated cefixime uptake into human intestinal epithelial cells is increased by Ca2+ channel blockers.

Authors:  Uwe Wenzel; Sabine Kuntz; Simone Diestel; Hannelore Daniel
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

4.  Effect of Excessive Serotonin on Pharmacokinetics of Cephalexin after Oral Administration: Studies with Serotonin-Excessive Model Rats.

Authors:  Shun Nakashima; Takeharu Iwamoto; Masashi Takanashi; Ken-Ichi Ogawara; Masato Maruyama; Kazutaka Higaki
Journal:  Pharm Res       Date:  2022-07-08       Impact factor: 4.580

Review 5.  The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology.

Authors:  Hannelore Daniel; Gabor Kottra
Journal:  Pflugers Arch       Date:  2003-08-07       Impact factor: 3.657

6.  Expression and regulation of the proton-coupled oligopeptide transporter PhT2 by LPS in macrophages and mouse spleen.

Authors:  Yuqing Wang; Dongli Sun; Feifeng Song; Yongjun Hu; David E Smith; Huidi Jiang
Journal:  Mol Pharm       Date:  2014-05-02       Impact factor: 4.939

Review 7.  Protein Kinases C-Mediated Regulations of Drug Transporter Activity, Localization and Expression.

Authors:  Abdullah Mayati; Amélie Moreau; Marc Le Vée; Bruno Stieger; Claire Denizot; Yannick Parmentier; Olivier Fardel
Journal:  Int J Mol Sci       Date:  2017-04-04       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.